Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Takeda will cut 2,800 jobs to integrate Nycomed

18-Jan-2012

Related topics: Regulatory & Safety

Takeda has announced it will cut 2,800 jobs by 2015 as part of its integration of Nycomed.

Osaka, Japan-based Takeda – which bought Swiss drugmaker Nycomed in September last year – said the cuts will be across its R&D and commercial operations with 2,100 jobs being lost in Europe and the remainder being in the US.

Takeda also said that as part of the integration plan it will consolidate its R&D (research and development) sites in Europe but did not go into specifics.

“The necessary cost for this plan is estimated approximately Yen 70bn ($911m) in total during fiscal 2011 – 2015. During this period, Takeda will achieve cost synergies of approximately Yen 200bn.

The firm also forecast that the financial impact of the cuts in the financial year ending in March will be around Yen 35bn and said that it will revise its forecasts accordingly.

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.